Mattingly is an associate professor and vice chair of research in the Department of Pharmacotherapy at the University of Utah ...

The FDA has approved a first-of-its-kind treatment for dry age-related macular degeneration (AMD), a leading cause of blindness in adults over 55.

This prestigious honor highlights Ms. McKeever's transformative contributions to Photobiomodulation (PBM) therapy, her exceptional leadership, and her dedication to advancing holistic health ...

The new document focuses on the influence of PBMs over the market for specialty generic drugs for illnesses like cancer, ...

In today’s dynamic, customizable wellness landscape, brands have a unique opportunity to stay ahead of the curve.

Several large drugmakers will ask the Trump administration to pause Medicare drug-price negotiations, even as Biden-appointed ...

The UnitedHealth Group is overcharging patients for necessary life-saving drugs as a result of price gouging that increases ...

In addition, certain areas of therapy, such as self-administered injectables ... In the meantime, the PBM industry is doing an excellent job of convincing employers of the benefits of carving ...

This includes physician services, rehab therapy services ... of the bill that shine a light on what they consider inequitable PBM practices as a great initial effort to rectify a substantial ...

For example: A PBM that retains a portion of rebates will ... Placing biosimilars on the formulary and helping patients transition therapy resulted in at least a 20% reduction in TIMs drug costs ...